Top Clinical Trials companies in Taiwan by Gross Profit

This ranking features the top 3 Clinical Trials companies in Taiwan ranked by Gross Profit, totalling a Gross Profit of USD 24.61 M, for January 15, 2025.

Taiwan

Clinical Trials
Gross Profit
#
Name
Gross Profit
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
4128.TWO

Microbio Co., Ltd.

1

4128.TWO
USD 19.67 M
Dec. 31, 2023 USD 0.93 4.52%

Taiwan
2
4147.TWO

TaiMed Biologics Inc.

2

4147.TWO
USD 7.34 M
Dec. 31, 2023 USD 2.64 -2.78%

Taiwan
3
4174.TWO

OBI Pharma, Inc.

3

4174.TWO
USD -2.39 M
Dec. 31, 2023 USD 1.70 1.57%

Taiwan
Frequently Asked Questions
  • Which Clinical Trials company in Taiwan has the highest Gross Profit ?

    The Clinical Trials company in Taiwan with the highest Gross Profit is Microbio Co., Ltd. (Taipei Exchange: 4128.TWO) at USD 19.67 M.

  • Which Clinical Trials company in Taiwan has the lowest Gross Profit ?

    The Clinical Trials company in Taiwan with the lowest Gross Profit is OBI Pharma, Inc. (Taipei Exchange: 4174.TWO) at USD -2.39 M.